Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Archives of Gynecology and Obstetrics
Published in: Archives of Gynecology and Obstetrics 2/2015

01-02-2015 | Gynecologic Endocrinology and Reproductive Medicine

The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome

Authors: Cristina Laguna Benetti-Pinto, Silvia Regina Ferreira, Armando Antunes Jr., Daniela Angerame Yela

Published in: Archives of Gynecology and Obstetrics | Issue 2/2015

Login to get access

Abstract

Purpose

To assess sexual function (SF) and quality of life (QOL) in women with polycystic ovary syndrome (PCOS).

Methods

A cross-sectional study was conducted to assess 56 women with PCOS and 102 control women with regular menstrual cycles. To assess SF and QOL in Brazilian women with PCOS with Female Sexual Function Index (FSFI) and the WHOQOL-bref questionnaires.

Results

Women with PCOS had a worse evaluation to arousal, lubrication, satisfaction, pain and total FSFI, and there was no difference in sexual desire and orgasm. Besides, they had a worse evaluation concerning health status than controls. The body mass index was inversely correlated to the QOL, especially to the physical, psychological, environment aspects and self-assessment of QOL, but it did not show correlation to the SF.

Conclusion

Women with PCOS had a worse sexual function and self-assessment of health condition in comparison to controls. The body weight as isolated symptom was correlated to the worsening in quality of life, but not with the worsening of sexual function.
Literature
1.
Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 81:19–25
2.
Fauser BC, Tarlatzis BC, Rebar RW, Legro RS, Balen AH, Lobo R et al (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS) the Amsterdam ESHERE/ASRM-Sponsored 3rd POCS Workshop Group. Fertil Steril 97:28–38PubMedCrossRef
3.
Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE (2007) Glucose intolerance in polycystic ovary syndrome—a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 92:4546–4556PubMedCrossRef
4.
Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group (2012) Consensus on women’s health aspects of polycystic ovary syndrome (PCOS). Hum Reprod 27:14–24CrossRef
5.
Niet JE, Koning CM, Pastoor H, Duivevvoorden HJ, Valkenburg O, Ramakers MJ et al (2010) Psychological well-being and sexarche in women with polycystic ovary syndrome. Hum Reprod 25:1497–1503PubMedCrossRef
6.
McCook Reame NE, Thatcher SS (2005) Health related quality of life issues in women with polycystic ovary syndrome. J Obstet Gynecol Neonatal Nurs 34:12–20CrossRef
7.
Jones GL, Hale JM, Balen AH, Ledger WL (2008) Health-related quality of life measurement in women with polycystic ovary syndrome: a systematic review. Hum Reprod Update 14:15–25PubMedCrossRef
8.
Barth JH, Catalan J, Cherry CA, Day A (1993) Psychological morbidity in women referred for treatment of hirsutism. J Psychosom Res 37:615–619PubMedCrossRef
9.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY (1999) The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 140:672–676PubMedCrossRef
10.
Downey J, Yingling S, McKinney M, Husami N, Jewelewicz R, Maidman J (1989) Mood disorders, psychiatric symptoms, and distress in women presenting for infertility evaluation. Fertil Steril 52:425–432PubMed
11.
Kocelak P, Chudek J, Naworska B, Sosnowska K, Kotlarz B, Mazurek M et al (2012) Psychological disturbances and quality of life in obese and infertile women and men. Int J Endocrinol 5:1–14CrossRef
12.
Malik-Aslam A, Reaney MD, Speight J (2010) The suitability of polycystic ovary syndrome-specific questionnaires for measuring the impact of PCOS on quality of life in clinical trials. Value Health 13:440–446PubMedCrossRef
13.
Thomson RL, Buckey JD, Lim SS, Noakes M, Clifton PM, Norman RJ et al (2010) Lifestyle management improves quality of life and depression in overweight and obese women with polycystic ovary syndrome. Fertil Steril 94:1812–1816PubMedCrossRef
14.
Ercan CM, Coksuer H, Aydogan U, Alanbay I, Keskin U, Karasahin KE et al (2013) Sexual dysfunction assessment and hormonal correlations in patients with polycystic ovary syndrome. Int J Impot Res 25:127–132PubMedCrossRef
15.
16.
Ferriman D, Gallwey JD (1961) Clinical assessment of body hair growth in women. J Clin Endocrinol Metab 21:1440–1447PubMedCrossRef
17.
Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al (2000) The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 26:191–208PubMedCrossRef
18.
Meston CM, Derogatis LR (2002) Validated instruments for assessing female sexual function. J Sex Marital Ther 28:155–164PubMedCrossRef
19.
Fleck MPA, Louzada S, Xavier M, Chachamovich E, Vieira G, Santos L et al (2000) Aplicação da versão em português do instrumento abreviado de avaliação da qualidade de vida “WHOQOL-bref”. Rev Saúde Publica 34:178–183
20.
The WHOQOL Group (1994) Development of the World Health Organization quality of life assessment instrument (the WHOQOL). In: Orley J, Kuyken W (eds) Quality of life assessment: international perspectives. Springer, Heidelberg, pp 41–69
21.
Tan S, Hahn S, Benson S, Janssen OE, Dietz T, Kimmig R et al (2008) Psycological implications of infertility in women with polycystic ovary syndrome. Human Reprod 23:2064–2071CrossRef
22.
Elsembruch S, Hahn S, Kowalsky D, Offner H, Schedlowski M, Mann K, Janssen OE (2003) Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome. J Clin Endocrinol Metab 88:5801–5807CrossRef
23.
Hahn S, Janssen OE, Tan S, Pleger K, Mann K, Schedlowski M, Kimmig R, Benson S et al (2005) Clinical and psychological correlates of quality of life in polycystic ovary syndrome. Eur J Endocrinol 153:853–860PubMedCrossRef
24.
Mansson M, Norstro¨m K, Holte J, Landin-Wilhelmsen K, Dahlgren E, Lande´n M (2011) Sexuality and psychological wellbeing in women with polycystic ovary syndrome compared with healthy controls. Eur J Obstet Gynecol Reprod Biol 155:161PubMedCrossRef
25.
Drosdzol A, Skrzypulec V, Mazur B, Pawlińska-Chmara R (2007) Quality of life and marital sexual satisfaction in women with polycystic ovary syndrome. Folia Histochem Cytobiol 45:S93–S97PubMed
26.
Kaneshiro B, Jensen JT, Carlson NE, Harvey SM, Nichols MD, Edelman AB (2008) Body mass index and sexual behavior. Obstet Gynecol 112:586–592PubMedCrossRef
Metadata
Title
The influence of body weight on sexual function and quality of life in women with polycystic ovary syndrome
Authors
Cristina Laguna Benetti-Pinto
Silvia Regina Ferreira
Armando Antunes Jr.
Daniela Angerame Yela
Publication date
01-02-2015
Publisher
Springer Berlin Heidelberg
Published in
Archives of Gynecology and Obstetrics / Issue 2/2015
Print ISSN: 0932-0067
Electronic ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-014-3423-1

Other articles of this Issue 2/2015

Archives of Gynecology and Obstetrics 2/2015 Go to the issue

Review

Primary hyperparathyroidism during pregnancy

Gynecologic Endocrinology and Reproductive Medicine

Routine use of EmbryoGlue® as embryo transfer medium does not improve the ART outcomes

General Gynecology

University Gynaecology and Obstetrics, quo vadis? A Department of Women’s Health—University Women’s Hospital of the future?

Editorial

New Associate Editor Prof. Dr. Ivo Meinhold-Heerlein

Maternal-Fetal Medicine

Calculating probability of requiring allogeneic blood transfusion using three preoperative risk factors on cesarean section for placenta previa

Gynecologic Oncology

The expression of GLTSCR2 in cervical intra-epithelial lesion and cancer